相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma
H. Gurler Main et al.
ONCOGENE (2017)
Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer
Kostandinos Sideras et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Donnele Daley et al.
NATURE MEDICINE (2017)
Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
Chun-Xia Ren et al.
ONCOLOGY REPORTS (2017)
Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
Yidong Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
Kostandinos Sideras et al.
ONCOIMMUNOLOGY (2017)
The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
Isabel Goncalves Silva et al.
EBIOMEDICINE (2017)
Phenotype, function, and differentiation potential of human monocyte subsets
Lisa B. Boyette et al.
PLOS ONE (2017)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells
Nobuhisa Takase et al.
CANCER LETTERS (2016)
Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma
Elizabeth Ann L. Enninga et al.
MELANOMA RESEARCH (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Marie Genin et al.
BMC CANCER (2015)
GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor-associated macrophages
Fangyu Zhu et al.
ONCOLOGY REPORTS (2015)
Apoptosis of tumor infiltrating effector TIM-3+CD8+T cells in colon cancer
Chiao-Wen Kang et al.
SCIENTIFIC REPORTS (2015)
Fractalkine Promotes Human Monocyte Survival via a Reduction in Oxidative Stress
Gemma E. White et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
Chuan Wu et al.
IMMUNITY (2014)
Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies
Shravan Madireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
G. J. K. Guthrie et al.
BRITISH JOURNAL OF CANCER (2013)
Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation
Friederike Gieseke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
TIM-3 Does Not Act as a Receptor for Galectin-9
Judith Leitner et al.
PLOS PATHOGENS (2013)
Tumour-infiltrating macrophages and clinical outcome in breast cancer
S. M. A. Mahmoud et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Jonas Fuxe et al.
SEMINARS IN CANCER BIOLOGY (2012)
Galectin-9 regulates T helper cell function independently of Tim-3
Ee W. Su et al.
GLYCOBIOLOGY (2011)
Obstacles and opportunities for understanding macrophage polarization
Peter J. Murray et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry
Shuguang Bi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Wendy K. Nevala et al.
CLINICAL CANCER RESEARCH (2009)
Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors
T. John et al.
ONCOGENE (2009)
Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition
Masamichi Nagae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
Toru Nakanishi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Blood monocytes consist of two principal subsets with distinct migratory properties
F Geissmann et al.
IMMUNITY (2003)
Systemic inflammatory response predicts survival following curative resection of colorectal cancer
DC McMillan et al.
BRITISH JOURNAL OF SURGERY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Regulation of galectin-9 expression and release in Jurkat T cell line cells
S Chabot et al.
GLYCOBIOLOGY (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)